Sex Differences In Clinical Outcomes Among Patients With Stress-induced Cardiomyopathy Complicated By Cardiogenic Shock: A Retrospective Multi-center Cohort Study
Gina C Josey , Usman Hasnie , Vibhu Parcha , Ahmed Saleh , Ammar Hasnie , Samuel McElwee , Stephen Clarkson
{"title":"Sex Differences In Clinical Outcomes Among Patients With Stress-induced Cardiomyopathy Complicated By Cardiogenic Shock: A Retrospective Multi-center Cohort Study","authors":"Gina C Josey , Usman Hasnie , Vibhu Parcha , Ahmed Saleh , Ammar Hasnie , Samuel McElwee , Stephen Clarkson","doi":"10.1016/j.cardfail.2024.10.047","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Stress-Induced cardiomyopathy, which disproportionately impacts post-menopausal females, may be complicated by cardiogenic shock. However, sex-specific clinical outcomes among patients with stress-induced cardiomyopathy complicated by cardiogenic shock remains relatively understudied.</div></div><div><h3>Methods</h3><div>This is a retrospective cohort study using an EHR-based data platform from large academic medical centers across the United States (TriNetX, Inc.). We identified a study population of patients diagnosed with cardiogenic shock secondary to stress-induced cardiomyopathy from January 2012 through January 2024. Baseline demographics, clinical characteristics, medication use, and outcomes were defined using standardized ICD-10 codes. We stratified patients by sex, with the primary outcome of all-cause mortality at 6 months. Secondary outcomes included cardiac arrest, acute kidney injury (AKI), atrial fibrillation, and ventricular tachycardia/fibrillation (VT/VF). Propensity score matching (1:1), incorporating demographic factors, comorbidities, and medication usage, was employed to compare the risk of primary and secondary outcomes between groups.</div></div><div><h3>Results</h3><div>A total of 4,519 individuals were identified as having cardiogenic shock secondary to stress-induced cardiomyopathy. After propensity-score matching, there were 1,476 individuals in each group (<strong>Table</strong>). Females had a lower risk of all-cause mortality compared with their male counterparts (33.2% vs. 40.7%, HR: 0.78, 95% CI: 0.69-0.88). The females had lower risk of AKI (HR: 0.73, 95% CI: 0.66-0.80), cardiac arrest (HR: 0.86, 95% CI: 0.73-1.00), and VT/VF (HR: 0.76, 95% CI: 0.63-0.92). The risk of atrial fibrillation was similar between males and females (HR: 0.90, 95% CI: 0.76-1.06).</div></div><div><h3>Conclusion</h3><div>This study unveils a sex-based disparity in clinical outcomes among individuals with stress cardiomyopathy complicated by cardiogenic shock, underscoring the potential influence of sex-specific factors in the pathophysiology of this condition. Further investigations are warranted into the mechanistic underpinnings of sex-associated disparities and for tailoring therapeutic strategies to optimize clinical outcomes.</div></div>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":"31 1","pages":"Page 197"},"PeriodicalIF":6.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S107191642400469X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Stress-Induced cardiomyopathy, which disproportionately impacts post-menopausal females, may be complicated by cardiogenic shock. However, sex-specific clinical outcomes among patients with stress-induced cardiomyopathy complicated by cardiogenic shock remains relatively understudied.
Methods
This is a retrospective cohort study using an EHR-based data platform from large academic medical centers across the United States (TriNetX, Inc.). We identified a study population of patients diagnosed with cardiogenic shock secondary to stress-induced cardiomyopathy from January 2012 through January 2024. Baseline demographics, clinical characteristics, medication use, and outcomes were defined using standardized ICD-10 codes. We stratified patients by sex, with the primary outcome of all-cause mortality at 6 months. Secondary outcomes included cardiac arrest, acute kidney injury (AKI), atrial fibrillation, and ventricular tachycardia/fibrillation (VT/VF). Propensity score matching (1:1), incorporating demographic factors, comorbidities, and medication usage, was employed to compare the risk of primary and secondary outcomes between groups.
Results
A total of 4,519 individuals were identified as having cardiogenic shock secondary to stress-induced cardiomyopathy. After propensity-score matching, there were 1,476 individuals in each group (Table). Females had a lower risk of all-cause mortality compared with their male counterparts (33.2% vs. 40.7%, HR: 0.78, 95% CI: 0.69-0.88). The females had lower risk of AKI (HR: 0.73, 95% CI: 0.66-0.80), cardiac arrest (HR: 0.86, 95% CI: 0.73-1.00), and VT/VF (HR: 0.76, 95% CI: 0.63-0.92). The risk of atrial fibrillation was similar between males and females (HR: 0.90, 95% CI: 0.76-1.06).
Conclusion
This study unveils a sex-based disparity in clinical outcomes among individuals with stress cardiomyopathy complicated by cardiogenic shock, underscoring the potential influence of sex-specific factors in the pathophysiology of this condition. Further investigations are warranted into the mechanistic underpinnings of sex-associated disparities and for tailoring therapeutic strategies to optimize clinical outcomes.
期刊介绍:
Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.